PT005 MDI Dose Ranging Versus Foradil Aerolizer Study
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of inhaled PT005 MDI
compared to placebo and Foradil Aerolizer in patients with moderate to severe chronic
obstructive pulmonary disease (COPD).